Free Trial

Cooper Companies (COO) Competitors

Cooper Companies logo
$81.67 -0.56 (-0.68%)
As of 04/30/2025 04:00 PM Eastern

COO vs. WST, ALGN, MMSI, ICUI, HAE, XRAY, QDEL, NEOG, STAA, and CERS

Should you be buying Cooper Companies stock or one of its competitors? The main competitors of Cooper Companies include West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), and Cerus (CERS). These companies are all part of the "health care supplies" industry.

Cooper Companies vs.

West Pharmaceutical Services (NYSE:WST) and Cooper Companies (NASDAQ:COO) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings, community ranking, media sentiment and institutional ownership.

West Pharmaceutical Services presently has a consensus price target of $332.50, suggesting a potential upside of 57.50%. Cooper Companies has a consensus price target of $110.25, suggesting a potential upside of 34.99%. Given West Pharmaceutical Services' stronger consensus rating and higher probable upside, research analysts plainly believe West Pharmaceutical Services is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
West Pharmaceutical Services
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.00
Cooper Companies
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70

West Pharmaceutical Services has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500. Comparatively, Cooper Companies has a beta of 1.01, indicating that its share price is 1% more volatile than the S&P 500.

93.9% of West Pharmaceutical Services shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 0.6% of West Pharmaceutical Services shares are owned by insiders. Comparatively, 2.0% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, West Pharmaceutical Services had 14 more articles in the media than Cooper Companies. MarketBeat recorded 42 mentions for West Pharmaceutical Services and 28 mentions for Cooper Companies. Cooper Companies' average media sentiment score of 0.97 beat West Pharmaceutical Services' score of 0.74 indicating that Cooper Companies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
West Pharmaceutical Services
19 Very Positive mention(s)
1 Positive mention(s)
13 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive
Cooper Companies
16 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Positive

West Pharmaceutical Services has a net margin of 17.03% compared to Cooper Companies' net margin of 10.07%. West Pharmaceutical Services' return on equity of 18.60% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
West Pharmaceutical Services17.03% 18.60% 13.80%
Cooper Companies 10.07%9.38%6.09%

Cooper Companies received 354 more outperform votes than West Pharmaceutical Services when rated by MarketBeat users. Likewise, 66.42% of users gave Cooper Companies an outperform vote while only 56.11% of users gave West Pharmaceutical Services an outperform vote.

CompanyUnderperformOutperform
West Pharmaceutical ServicesOutperform Votes
271
56.11%
Underperform Votes
212
43.89%
Cooper CompaniesOutperform Votes
625
66.42%
Underperform Votes
316
33.58%

West Pharmaceutical Services has higher earnings, but lower revenue than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
West Pharmaceutical Services$2.90B5.24$492.70M$6.3733.14
Cooper Companies$3.93B4.16$392.30M$2.0639.65

Summary

West Pharmaceutical Services beats Cooper Companies on 12 of the 19 factors compared between the two stocks.

Get Cooper Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COO vs. The Competition

MetricCooper CompaniesOphthalmic goods IndustryMedical SectorNASDAQ Exchange
Market Cap$16.33B$11.18B$5.57B$7.83B
Dividend YieldN/A0.96%5.11%4.21%
P/E Ratio41.8835.9922.4418.48
Price / Sales4.162.81394.10103.59
Price / Cash15.8714.5338.1834.62
Price / Book2.022.386.774.25
Net Income$392.30M$224.27M$3.22B$248.23M
7 Day Performance1.03%2.36%3.25%3.29%
1 Month Performance-2.51%-11.73%0.01%2.42%
1 Year Performance-8.30%-19.44%18.00%5.54%

Cooper Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COO
Cooper Companies
3.3067 of 5 stars
$81.67
-0.7%
$110.25
+35.0%
-8.3%$16.33B$3.93B41.8814,000
WST
West Pharmaceutical Services
4.6418 of 5 stars
$206.02
+2.0%
$332.50
+61.4%
-40.9%$14.89B$2.89B30.8010,700Earnings Report
Dividend Announcement
Analyst Revision
ALGN
Align Technology
4.3503 of 5 stars
$172.22
+0.5%
$256.90
+49.2%
-38.6%$12.61B$4.00B30.7023,200Analyst Forecast
News Coverage
MMSI
Merit Medical Systems
3.9633 of 5 stars
$89.60
-1.4%
$114.33
+27.6%
+27.5%$5.29B$1.36B43.926,850Earnings Report
Short Interest ↑
Analyst Revision
ICUI
ICU Medical
3.8494 of 5 stars
$136.72
-1.4%
$162.67
+19.0%
+39.5%$3.35B$2.38B-29.9214,500Upcoming Earnings
Positive News
HAE
Haemonetics
4.6271 of 5 stars
$57.03
-0.2%
$101.22
+77.5%
-31.5%$2.87B$1.37B22.452,820Positive News
XRAY
DENTSPLY SIRONA
4.8967 of 5 stars
$12.82
-0.1%
$22.58
+76.2%
-53.7%$2.55B$3.79B-6.1915,000Analyst Forecast
Positive News
QDEL
QuidelOrtho
4.4311 of 5 stars
$24.56
-2.4%
$46.83
+90.7%
-31.5%$1.66B$2.78B-0.817,000Upcoming Earnings
NEOG
Neogen
3.7916 of 5 stars
$4.69
+6.8%
$9.75
+107.9%
-59.0%$1.02B$906.00M-2.142,110High Trading Volume
STAA
STAAR Surgical
4.3746 of 5 stars
$16.53
-2.1%
$24.25
+46.7%
-60.3%$815.34M$313.90M-40.32960Upcoming Earnings
CERS
Cerus
2.078 of 5 stars
$1.29
-0.8%
$3.50
+171.3%
-21.0%$239.67M$180.27M-11.73290Upcoming Earnings
News Coverage

Related Companies and Tools


This page (NASDAQ:COO) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners